Report Discusses POC Testing and Changing Paradigms
|
By LabMedica International staff writers Posted on 20 Jun 2017 |

Image: A new report suggests utilization of trained personnel and evaluation of tests will help ensure that best-quality tests are ordered and interpreted correctly to benefit patient care (Photo courtesy of the American Society for Microbiology).
The American Academy of Microbiology has released a new report on the role of the role of point-of-care (POC) and near-patient testing in changing diagnostic paradigms in microbiology.
Technology for diagnosing infectious diseases in patients is rapidly advancing, and new diagnostic tests have the potential to meaningfully improve patient care. Recommendations for the Academy’s report (Changing Diagnostic Paradigms for Microbiology, published May 2017) were based on discussions of a panel of experts. The Academy convened a colloquium October 17-18, 2016, (Washington, DC; USA) to explore the development and implementation of near-patient and POC testing and to provide recommendations for using these tests to improve patient care across clinical settings.
“Rapid diagnostic tests have the potential to deliver timely results, enable treatment decisions by detecting the presence of biomarkers, distinguish between viral and bacterial infections, identify causative organisms, and provide information on drug resistance,” said Melissa Miller, PhD, steering committee chair of the colloquium. The report focuses on the unmet needs for research and development of new diagnostic tests, for ongoing regulatory review of POC tests, and for laboratorian expertise, even in near-patient settings. The participants also discussed the importance of proper interpretation of test results, and linking test results to electronic medical records. They emphasized the need for microbiology experts to guide the development and utilization of tests and ensure proper reporting of results.
“The expertise of clinical microbiologists is essential to maximizing the value and minimizing the risk of POC infectious disease diagnostics, provided that clinical microbiologists adapt their practice to this setting,” said Sheldon Campbell, MD, PhD, Yale School of Medicine, a participant in the colloquium.
The report summarized proper utilization of tests (such as ordering appropriate tests and correctly interpreting results), the need for proper training and education on test usage, and contamination concerns. It also discussed regulation of the tests (reporting issues to FDA, CMS requirements), and the importance of documenting results and reporting to health departments when necessary. For the future, participants agreed that POC tests should be linked to web-based quality and performance matrices that would revolutionize POC testing quality and reach.
A commentary with additional information on advances in diagnostics, Advances Afoot in Microbiology by Mayo Clinic’s Patel R and Karon BS, was published May 24, 2017, in the Journal of Clinical Microbiology.
Technology for diagnosing infectious diseases in patients is rapidly advancing, and new diagnostic tests have the potential to meaningfully improve patient care. Recommendations for the Academy’s report (Changing Diagnostic Paradigms for Microbiology, published May 2017) were based on discussions of a panel of experts. The Academy convened a colloquium October 17-18, 2016, (Washington, DC; USA) to explore the development and implementation of near-patient and POC testing and to provide recommendations for using these tests to improve patient care across clinical settings.
“Rapid diagnostic tests have the potential to deliver timely results, enable treatment decisions by detecting the presence of biomarkers, distinguish between viral and bacterial infections, identify causative organisms, and provide information on drug resistance,” said Melissa Miller, PhD, steering committee chair of the colloquium. The report focuses on the unmet needs for research and development of new diagnostic tests, for ongoing regulatory review of POC tests, and for laboratorian expertise, even in near-patient settings. The participants also discussed the importance of proper interpretation of test results, and linking test results to electronic medical records. They emphasized the need for microbiology experts to guide the development and utilization of tests and ensure proper reporting of results.
“The expertise of clinical microbiologists is essential to maximizing the value and minimizing the risk of POC infectious disease diagnostics, provided that clinical microbiologists adapt their practice to this setting,” said Sheldon Campbell, MD, PhD, Yale School of Medicine, a participant in the colloquium.
The report summarized proper utilization of tests (such as ordering appropriate tests and correctly interpreting results), the need for proper training and education on test usage, and contamination concerns. It also discussed regulation of the tests (reporting issues to FDA, CMS requirements), and the importance of documenting results and reporting to health departments when necessary. For the future, participants agreed that POC tests should be linked to web-based quality and performance matrices that would revolutionize POC testing quality and reach.
A commentary with additional information on advances in diagnostics, Advances Afoot in Microbiology by Mayo Clinic’s Patel R and Karon BS, was published May 24, 2017, in the Journal of Clinical Microbiology.
Latest Microbiology News
- Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
- Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
- WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
- New Imaging Approach Could Help Predict Dangerous Gut Infection
- Rapid Sequencing Could Transform Tuberculosis Care
- Blood-Based Viral Signature Identified in Crohn’s Disease
- Hidden Gut Viruses Linked to Colorectal Cancer Risk
- Three-Test Panel Launched for Detection of Liver Fluke Infections
- Rapid Test Promises Faster Answers for Drug-Resistant Infections
- CRISPR-Based Technology Neutralizes Antibiotic-Resistant Bacteria
- Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
- AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
- New Test Measures How Effectively Antibiotics Kill Bacteria
- New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics
- New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
- Breakthroughs in Microbial Analysis to Enhance Disease Prediction
Channels
Clinical Chemistry
view channel
Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, with more than 60% of cases still diagnosed at a late stage. Uptake of existing screening tools remains suboptimal,... Read more
Automated NfL Assay Supports Monitoring of Neurological Disorders
Neuroaxonal injury occurs across a wide range of neurological disorders and remains difficult to monitor noninvasively over time. Blood-based measurement of neurofilament light chain (NfL) provides a biologically... Read moreMolecular Diagnostics
view channel
New Respiratory Panel Expands Pathogen Detection to 25 Targets
Respiratory infections often present with overlapping symptoms, complicating differential diagnosis in acute and community settings. The stakes are higher for older adults, young children, and people with... Read more
Simple Nasal Swab May Reveal Early Signs of Alzheimer’s Disease
Alzheimer’s disease affects millions worldwide but remains difficult to detect at its earliest, pre-symptomatic stage. Clinicians need tools that can identify biological changes before cognitive symptoms... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreTechnology
view channel
Online Tool Supports Family Screening for Inherited Cancer Risk
Genetic test results in oncology often have implications for relatives who may share inherited cancer risk. Many health systems lack structured processes to help patients alert family members, limiting... Read more
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more








